EMBCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30

Embecta Corp.

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$6.21−0.06 (-0.96%)

Close on Oct 19, 2026

Market cap: $363.36M
P/E (TTM): 4.2
Dividend yield: 9.66%

Embecta Corp. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-09-30	FY 2024 2024-09-30	FY 2023 2023-09-30	FY 2022 2022-09-30	FY 2021 2021-09-30	FY 2020 2020-09-30	FY 2019 2019-09-30
Cash & Equivalents	226	274	327	331	0	0	0
Cash & Short-Term Investments	226	274	327	331	0	0	0
Receivables	146	193	17	22	151	–	–
Inventory	179	172	152	123	118	–	–
Other Current Assets	75	69	111	78	23	–	–
Total Current Assets	631	761	749	665	292	–	–
Property, Plant & Equipment	257	290	300	302	451	–	–
Gross Property, Plant & Equipment	–	–	–	–	892	–	–
Accumulated Depreciation	–	–	–	–	-441	–	–
Operating Lease Right-of-Use Assets	20	23	23	6.30	3.90	–	–
Goodwill	15	16	16	16	16	–	–
Intangible Assets	7.00	8.10	9.10	8.90	18	–	–
Other Long-Term Assets	–	–	–	–	11	–	–
Total Assets	1,091	1,285	1,214	1,086	788	–	–
Accounts Payable	–	–	–	–	54	–	–
Accrued Expenses	99	134	118	104	82	–	–
Current Portion of Long-Term Debt	9.50	9.50	9.50	9.50	0	–	–
Current Debt	9.50	9.50	9.50	9.50	0	–	–
Current Portion of Leases	6.90	6.00	5.90	2.00	1.10	–	–
Current Income Taxes Payable	9.80	27	34	27	0	–	–
Total Current Liabilities	262	374	354	301	164	–	–
Long-Term Debt	1,389	1,565	1,594	1,598	0	–	–
Long-Term Leases	10	12	15	4.30	3.00	–	–
Operating Lease Liabilities	17	18	21	6.30	4.10	–	–
Total Liabilities	1,742	2,024	2,036	1,978	194	–	–
Total Debt	1,398	1,575	1,603	1,608	0	–	–
Common Stock	0.60	0.60	0.60	0.60	–	–	–
Additional Paid-In Capital	80	53	28	10	–	–	–
Retained Earnings	-446	-499	-541	-577	–	–	–
Comprehensive Income & Other	-286	-293	-309	-325	-271	–	–
Shareholders' Equity	-651	-738	-822	-891	594	572	577
Total Equity	-651	-738	-822	-891	594	572	577
Total Liabilities & Equity	1,091	1,285	1,214	1,086	788	–	–
Shares Outstanding(shares)	58	58	57	57	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 59.0%
Operating margin: 21.9%
Net margin: 8.6%
Return on equity, FY2025: -13.7%

Financial strength

Current ratio: 1.68
Debt to equity: -2.37
Debt to assets: 115.0%
Cash to current liabilities: 51.1%

Valuation

P/E ratio: 4.2
Price to sales: 0.36
Price to book: –
Dividend yield: 9.66%